Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 109,927 shares at $65.46 ($7.3M) on 2025-10-03, disclosed to the SEC on 2025-10-07.
Scheduled sale ($7.3M) by CHIEF TECHNICAL Operations OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.45 | 23,419 | $1.5M | 21.1% |
| 2 | $65.45 | 23,419 | $1.5M | 21.1% |
| 3 | $65.46 | 1,609 | $105K | 1.5% |
| 4 | $65.46 | 1,609 | $105K | 1.5% |
| 5 | $66.45 | 23,863 | $1.6M | 21.8% |
| 6 | $66.45 | 23,863 |
| $1.6M |
| 21.8% |
| 7 | $66.56 | 1,760 | $117K | 1.6% |
| 8 | $66.56 | 1,760 | $117K | 1.6% |
| 9 | $67.15 | 4,276 | $287K | 4.0% |
| 10 | $67.15 | 4,276 | $287K | 4.0% |
| 11 | $67.16 | 73 | $5K | 0.1% |
| Total | $66.05 avg | 109,927 | $7.3M | 100% |
| Filing → |
| PTCT | SELL | 2026-06-30 | $693K | — | Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-06-24 | $1.9M | — | Filing → |